OMARIDIN™ Audio Matrix: A Non-Pharmacological Modality for Neurophysiological Regulation and Systemic Coherence
1. What is the OMARIDIN™ Audio Matrix?
The OMARIDIN™ Audio Matrix is a patented audio-holographic technology developed within the Terapia Imanente® programme (Patent PD 1/0413, author — Acad. Volodymyr Naumenko).
It translates the vibrational spectrum of the physical OMARIDIN™ compound into an acoustic format designed to interact with the body’s bioinformational fields. The Audio Matrix therefore represents a wave-based equivalent of the biological product and is applied as a non-pharmacological modality intended to support the body’s self-regulatory processes.
2. Scientific Rationale
Contemporary biophysics recognises that life processes are regulated not only biochemically, but also through electromagnetic field mechanisms.
Research by F.-A. Popp, Blank & Goodman, Mae-Wan Ho, and Albrecht-Buehler has suggested that:
- Living cells emit biophotons — ultra-weak light signals involved in intercellular synchronisation;
- Low-intensity electromagnetic fields may modulate gene expression and cellular repair mechanisms;
- DNA may function as a linguistic-wave code capable of interacting with electromagnetic signals (see White Paper).
Terapia Imanente® integrates these findings with classical Nobel Prize–recognised research:
- Niels Finsen (1903) — photobiomodulation and tissue regeneration;
- Ilya Mechnikov (1908) — microbiota and immunity in ageing;
- Otto Warburg (1931) — cellular respiration and oxygen metabolism;
- Hall / Rosbash / Young (2017) — circadian rhythms and biological timing.
3. Mechanism of Action
Conversion of Molecular Vibrations into Sound
The molecular oscillatory spectrum of the OMARIDIN™ compound is digitised into acoustic frequencies aligned with natural biological resonance ranges (approximately 431–432 Hz).
Resonance with the Human Biofield
During listening, acoustic waves may stimulate subtle electromagnetic and photonic oscillations in tissues, promoting a state of coherence — synchronisation of cellular rhythms.
Informational–Genetic Modulation
According to the Linguistic Electromagnetic Wave Genetic Code (LEWGC) concept, genetic structures may respond to resonance-based linguistic signals, potentially supporting metabolic and hormonal balance.
Synchronisation with Sleep and Self-Regulation
Research from the University of California (Berkeley, 2025) indicates that growth hormone release during sleep plays a central role in cellular regeneration.
The OMARIDIN™ Audio Matrix is designed to align with these biological rhythms, supporting natural nocturnal restorative processes.
Tissue Frequency Resonance
The Audio Matrix incorporates frequency ranges corresponding to seven natural body resonances described by Dr Paul Nogier (292–4672 Hz):
- 292 Hz — epidermis and nervous tissue
- 584 Hz — internal organs
- 1168 Hz — connective and muscular tissue
- 2336 Hz — stress modulation
- 4672 Hz — peripheral nervous system
- 73 Hz and 146 Hz — harmonic frequencies associated with hormonal balance and neural activity
4. Directions for Use
- Use in a calm environment, seated or lying down.
- Listen through headphones or acoustic speakers capable of transmitting frequencies between 20 Hz and 20 kHz.
- Recommended duration: 10–20 minutes, 1–2 times daily.
- Optimal timing: evening hours or before sleep, when endogenous regenerative systems are most active.
- No focused concentration is required — relaxed listening is sufficient.
- May be combined with the physical OMARIDIN™ product.
Participants in the Terapia Imanente® programme are advised to follow individually prescribed intervals (biorhythmic synchronisation as indicated in the physician or programme supervisor protocol).
⚠️ Contraindications:
Not recommended for individuals with epilepsy, severe psychoneurological disorders, while operating vehicles, or when using devices generating strong magnetic fields.
5. Certificates, Licences and Patents
Patent PD 1/0413 — “Terapia Imanente® / Slowing Down the Ageing Processes of the Organism”, author — Acad. Volodymyr Naumenko.
Copyright for the OMARIDIN™ Audio Matrix is registered by MB Patented MT (Lithuania) in cooperation with Kaunas University of Technology, Food Institute.
Safety has been confirmed by independent laboratories (2017 protocols, O.M. Marzeiev Institute for Public Health, National Academy of Medical Sciences of Ukraine), demonstrating the absence of toxic, microbiological, and radiological risks.
The scientific foundation of the programme is supported by international publications and research sources (NASA 2000; Max Planck Institute; Liebert Publishing; JAMA; Cell; The Lancet).